Niagen Bioscience (NAGE) Selling, General & Administrative (2010 - 2026)
Niagen Bioscience (NAGE) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Niagen Bioscience | 256.93 Mn | 190.38 Mn | 19.98 Mn | 7.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.24 Mn |
| Dec 31, 2025 | 7.48 Mn |
| Sep 30, 2025 | 7.13 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Mar 31, 2025 | 5.18 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 5.66 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 5.43 Mn |
| Sep 30, 2023 | 5.84 Mn |
| Jun 30, 2023 | 7.30 Mn |
| Mar 31, 2023 | 6.42 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 6.18 Mn |
| Jun 30, 2022 | 7.16 Mn |
| Mar 31, 2022 | 8.95 Mn |
| Dec 31, 2021 | 6.50 Mn |
| Sep 30, 2021 | 11.20 Mn |
| Jun 30, 2021 | 9.13 Mn |